Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas

Acta Histochemica

Volumn 115, Issue 8, 2013, Pages 795-802

  Cardile, Venera ^a   Malaponte, Grazia ^a   Loreto, Carla ^a   Libra, Massimo ^a   Caggia, Silvia ^a   Trovato, Francesca Maria ^a   Musumeci, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Cancer marker; Melanoma; Metastasis; PRKIP; RKIP

Indexed keywords

MEMBRANE PROTEIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHO PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; PEBP1 PROTEIN, HUMAN;

ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOMA; MELANOMA CELL; METASTASIS POTENTIAL; PIGMENTED NEVUS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKIN; WESTERN BLOTTING; BIOSYNTHESIS; CELL CULTURE; CHEMISTRY; METABOLISM; PATHOLOGY;

CELLS, CULTURED; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

EID: 84887209430     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2013.03.003     Document Type: Article

References (34)

1. Baritaki S., Yeung K., Palladino M., Berenson J., Bonavida B. Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization. Cancer Res 2009, 69:8376-8385.
2. Baritaki S., Chapman A., Yeung K., Spandidos D.A., Palladino M., Bonavida B. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction. Oncogene 2009, 28:3573-3585.
3. Caggia S., Libra M., Malaponte G., Cardile V. Modulation of YY1 and p53 expression by transforming growth factor-β3 in prostate cell lines. Cytokine 2011, 56:403-410.
4. Chatterjee D., Bai Y., Wang Z., Beach S., Mott S., Roy R. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 2004, 279:17515-17523.
5. Corbit K.C., Trakul N., Eves E.M., Diaz B., Marshall M., Rosner M.R. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 2003, 278:13061-13068.
6. Dangi-Garimella S., Yun J., Eves E.M., Newman M., Erkeland S.J., Hammond S.M., et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 2009, 28:347-358.
7. Das S.K., Bhutia S.K., Sokhi U.K., Azab B., Su Z.Z., Boukerche H., et al. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma. Cancer Res 2012, 72:6217-6226.
8. Eves E.M., Shapiro P., Naik K., Klein U.R., Trakul N., Rosner M.R. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 2006, 23:561-574.
9. Flaherty K.T. Chemotherapy and targeted therapy combinations in advanced melanoma. Clin Cancer Res 2006, 12:2366s-2370s.
10. Fu Z., Zhang P.C., Rubin L., Dunn M.A., Yao R.L., Keller E.T. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003, 95:878-889.
11. Goodglick L., Bonavida B. Clinical significance of RKIP and phosphorylated RKIP expression in human cancers. Forum Immun Dis Ther 2011, 2:171-178.
12. Huerta-Yepez S., Yoon N.K., Hernandez-Cueto A., Mah V., Rivera-Pazos C.M., Chatterjee D., et al. Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. BMC Cancer 2011, 11:259.
13. Keller E.T., Fu Z., Yeung K., Brennan M. Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene. Cancer Lett 2004, 207:131-137.
14. Ko J.M., Velez N.F., Tsao H. Pathways to melanoma. Semin Cutan Surg 2010, 29:210-217.
15. Li H.Z., Wang Y., Gao Y., Shao J., Zhao X.L., Deng W.M., et al. Effects of Raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer. Mol Cancer Res 2008, 6:917-928.
16. Lin K., Baritaki S., Militello L., Malaponte G., Bevelacqua Y., Bonavida B. The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-κB/Snail/RKIP/PTEN circuit. Genes Cancer 2010, 1:409-420.
17. Leonardi R., Loreto C., Talic N., Caltabiano R., Musumeci G. Immunolocalization of lubricin in the rat periodontal ligament during experimental tooth movement. Acta Histochem 2012, 114:700-704.
18. Leonardi R., Rusu M.C., Loreto F., Loreto C., Musumeci G. Immunolocalization and expression of lubricin in the bilaminar zone of the human temporomandibular joint disc. Acta Histochem 2012, 114:1-5.
19. Lorenz K., Lohse M.J., Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003, 426:574-579.
20. Loreto C., Lo Castro E., Musumeci G., Loreto F., Rapisarda G., Rezzani R., et al. Aquaporin 1 expression in human temporomandibular disc. Acta Histochem 2012, 114:744-748.
21. Miller A.J., Mihm M.C. Melanoma. N Engl J Med 2006, 355:51-65.
22. Musumeci G., Carnazza M.L., Leonardi R., Loreto C. Expression of beta-defensin-4 in "an in vivo and ex vivo model" of human osteoarthritic knee meniscus. Knee Surg Sports Traumatol Arthrosc 2012, 20:216-222.
23. Musumeci G., Carnazza M.L., Loreto C., Leonardi R. β-Defensin-4 (HBD-4) is expressed in chondrocytes derived from normal and osteoarthritic cartilage encapsulated in PEGDA scaffold. Acta Histochem 2012, 114:805-812.
24. Musumeci G., Loreto C., Leonardi R., Castorina S., Giunta S., Carnazza M.L., et al. The effects of physical activity on apoptosis and lubricin expression in articular cartilage in rats with glucocorticoid-induced osteoporosis. J Bone Miner Metab 2013, [Epub ahead of print].
25. Musumeci G., Leonardi R., Carnazza M.L., Cardile V., Pichler K., Weinberg A., et al. Aquaporin 1 (AQP1) expression in experimentally induced osteoarthritic knee menisci: an in vivo and in vitro study. Tissue Cell 2013, [Epub ahead of print].
26. Musumeci G., Loreto C., Carnazza M.L., Cardile V., Leonardi R. Acute injury affects lubricin expression in knee menisci: an immunohistochemical study. Annals Anat 2013, [Epub ahead of print].
27. Nottage M., Siu L.L. Rationale for Ras and Raf-kinase as a target for cancer therapeutic. Curr Pharm 2002, 22:31-42.
28. O'Neill E., Kolch W. Conferring specificity on the ubiquitous Raf//Mek signaling pathway. Br J Cancer 2004, 90:283-288.
29. Park S., Yeung M.L., Beach S., Shields J.M., Yeung K.C. RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene 2005, 24:3535-3540.
30. Schuierer M.M., Bataille F., Hagan S., Kolch W., Boserhoff A.K. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 2004, 64:5186-5192.
31. Yeung K., Seitz T., Li S., Janosch P., McFerran B., Kaiser C., et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999, 401:173-177.
32. Yeung K., Janosch P., McFerran B., Rose D.W., Mischak H., Sedivy J.M., et al. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the Raf kinase inhibitor protein. Mol Cell Biol 2000, 20:3079-3085.
33. Yeung K.C., Rose D.W., Dhillon A.S., Yaros D., Gustafsson M., Chatterjee D., et al. Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB. Mol Cell Biol 2001, 21:7207-7217.
34. Zaravinos A., Kanellou P., Baritaki S., Bonavida B., Spandidos D.A. BRAF and RKIP are significantly decreased in cutaneous squamous cell carcinoma. Cell Cycle 2009, 8:1402-1408.